GlassScriptPhysician profile
Debasish Mridha
NPI 1851327159
$24,229.73
in general payments reported to CMS, 2019-2025
70 companies · $4,069 in 2025
The $4,069 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,262 · 2020: $1,190 · 2021: $3,396 · 2022: $4,362 · 2023: $4,038 · 2024: $3,914 · 2025: $4,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,806.04 |
| Education | $214.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $2,151.19 | 2019-2025 | Mavenclad |
| Abbvie INC. | $2,074.77 | 2019-2025 | |
| Biogen, INC. | $1,829.49 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Ucb, INC. | $1,667.39 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Novartis Pharmaceuticals Corporation | $1,561.88 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,153.88 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Eisai INC. | $972.81 | 2019-2025 | |
| Harmony Biosciences LLC | $838.58 | 2021-2025 | |
| Genzyme Corporation | $760.52 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $717.90 | 2019-2025 | Ultomiris |
| Lilly USA, LLC | $714.60 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Neurocrine Biosciences, INC. | $661.75 | 2019-2025 | Ingrezza, Ongentys |
| Pfizer INC. | $613.22 | 2023-2025 | |
| Amgen INC. | $584.42 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $563.77 | 2021 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debasish Mridha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.